Genomic and environmental determinants of circular single-stranded DNA production in engineered E. coli

In the world of modern biotechnology, single strands of DNA are indispensable tools. These long, flexible chains of genetic code serve as the scaffolding for building microscopic structures, the templates for editing genes, and the blueprints for new medicines. For decades, scientists have relied on chemical factories to stitch these strands together, but this method hits a hard wall when the strands get too long; the process becomes slow, expensive, and prone to errors. Nature, however, has already solved this problem. A specific type of virus that infects bacteria, known as the M13 bacteriophage, naturally produces long, circular single strands of DNA as part of its life cycle. For years, researchers have tried to harness this viral machinery to mass-produce custom DNA strands, but the traditional methods have been messy. They often involve a complicated dance of helper viruses and plasmids that results in a final product filled with unwanted genetic debris, making it difficult to use for precise medical applications.

A team of researchers at the University of California, San Francisco, set out to clean up this process and make it scalable. They had previously engineered a strain of bacteria, which they named eScaf, that carries the viral DNA instructions directly in its own genetic code rather than relying on external helpers. This approach produced very pure DNA, but the amount harvested was far too small for practical use, yielding only a tiny fraction of what was needed for large-scale therapies. In their latest work, the team systematically tested how to coax these bacteria into producing much more DNA without losing that crucial purity. By tweaking the food the bacteria ate, changing the bacterial strain itself, and altering how many copies of the viral instructions were stored in the cell, they transformed a laboratory curiosity into a robust production system. They discovered that the amount of DNA produced depends heavily on where the viral instructions are placed in the bacterial genome and how many copies are present. Through a series of careful experiments, they increased the yield from roughly one hundred micrograms per liter to about four milligrams per liter, a forty-fold improvement that brings the technology close to the scale required for real-world medical manufacturing.

The journey began with a simple question: what does the bacteria need to eat to make the most DNA? The researchers grew their engineered bacteria in various nutrient-rich soups, comparing standard laboratory broth against more complex mixtures. They found that a rich, nutrient-dense broth called Terrific Broth did indeed help the bacteria produce more DNA, but it came with a catch. The final product was contaminated with extra, unwanted genetic material, lowering its purity. Another mixture, known as 2xYT, allowed the bacteria to grow larger but did not necessarily make them more efficient at producing the viral strands. The team realized they needed a custom solution that balanced growth with production. They formulated a new medium, which they called eScaf medium, by removing salt and adding specific ingredients like glycerol. This new recipe did something remarkable: it encouraged the bacteria to focus their energy on churning out the desired DNA strands rather than just growing larger cells. Using this optimized food source, the team saw the amount of usable DNA jump significantly, proving that what the bacteria consume directly dictates the quality and quantity of the genetic product they release.

With the food sorted, the researchers turned their attention to the bacteria themselves. They wondered if the specific genetic background of the host strain mattered. They tested the original bacteria against two other commercially available strains, one of which had been engineered for high-efficiency plasmid production. The results were striking. One of the new strains, derived from a strain called 5α, produced more than twice as much DNA as the original bacteria, while another strain produced even less. This suggested that the internal machinery of the cell plays a major role in how well the viral DNA is packaged and released. The team also experimented with adding a small molecular tag, a string of amino acids, to one of the viral coat proteins. This tag was intended to help with purification, but it had an unexpected side effect: it dramatically boosted the amount of DNA produced. The researchers suspect that this tag might help the virus particles exit the cell more efficiently, preventing them from getting stuck or reabsorbed, though the exact mechanism remains a subject for further study.

The final piece of the puzzle involved the number of viral instruction sets inside the bacteria. The original strain carried just one copy of the viral genome, a design chosen to prevent the virus from becoming toxic to the host. However, the team hypothesized that having more copies might increase production, provided the bacteria could handle the extra load. They successfully engineered strains with two, three, and even five copies of the viral genome integrated at different locations within the bacterial chromosome. They found that yield did not simply rise with every added copy; instead, the location of the integration mattered just as much as the number. A strain with five copies integrated at specific, high-performing locations produced the most DNA of all. When they combined this high-copy strain with their optimized food medium, the results were transformative. In a standard laboratory flask, the new strain, which they named eScaf-IS3, produced an average of 4.6 milligrams of DNA per liter of culture.

This level of production is a critical threshold. While the previous methods yielded only enough DNA for small-scale experiments, the new system generates quantities sufficient for high-throughput screening of potential therapies and the manufacturing of complex DNA structures used in advanced medicine. The researchers tested their system in large, controlled bioreactors and found that feeding strategies used in industrial fermentation could further support growth, suggesting that even higher yields are possible. The work demonstrates that by carefully tuning the environment and the genetic architecture of the host, it is possible to turn a simple bacterium into a highly efficient factory for custom DNA. This advancement removes a major bottleneck in the field, making it feasible to produce the long, pure strands of genetic code needed for next-generation treatments, from engineered immune cells to large-scale molecular machines, without the cost and complexity that previously limited their use.